XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Earnings - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]        
NET SALES $ 21,882 $ 21,441 $ 43,619 $ 43,312
Cost of products sold 10,418 10,144 20,839 20,645
Selling, general and administrative expense 5,723 5,522 11,242 11,127
Indefinite-lived intangible asset impairment charge 0 1,341 0 1,341
OPERATING INCOME 5,741 4,433 11,538 10,200
Interest expense (240) (248) (478) (472)
Interest income 119 133 254 262
Other non-operating income/(expense), net 224 177 (330) 309
EARNINGS BEFORE INCOME TAXES 5,845 4,496 10,985 10,299
Income taxes 1,187 1,003 2,339 2,250
NET EARNINGS 4,659 3,493 8,646 8,049
Less: Net earnings attributable to noncontrolling interests 29 25 56 60
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 4,630 $ 3,468 $ 8,589 $ 7,988
NET EARNINGS PER COMMON SHARE        
Basic (in dollars per share) [1] $ 1.94 $ 1.44 $ 3.59 $ 3.33
Diluted (in dollars per share) [1] $ 1.88 $ 1.40 $ 3.49 $ 3.23
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.